{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T17:41:30Z","timestamp":1760204490165},"reference-count":34,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Research in Developmental Disabilities"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.ridd.2010.07.003","type":"journal-article","created":{"date-parts":[[2010,8,9]],"date-time":"2010-08-09T04:24:32Z","timestamp":1281327872000},"page":"1135-1141","source":"Crossref","is-referenced-by-count":27,"title":["The use of clozapine among individuals with intellectual disability: A review"],"prefix":"10.1016","volume":"31","author":[{"given":"Ashvind N.","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johnny L.","family":"Matson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.D.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Russell D.","family":"Pella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher L.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela D.","family":"Adkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ridd.2010.07.003_bib1","first-page":"331","article-title":"The usefulness of thioridazine for treating childhood disorders: Fact or folklore?","volume":"84","author":"Aman","year":"1980","journal-title":"American Journal of Mental Deficiency"},{"key":"10.1016\/j.ridd.2010.07.003_bib2","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4088\/JCP.v61n0106","article-title":"Clozapine treatment in a population of adults with mental retardation","volume":"61","author":"Antonacci","year":"2000","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.ridd.2010.07.003_bib3","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1176\/jnp.10.1.93","article-title":"Use of clozapine in 10 mentally retarded adults","volume":"10","author":"Buzan","year":"1998","journal-title":"Journal of Neuropsychiatry"},{"key":"10.1016\/j.ridd.2010.07.003_bib4","first-page":"440","article-title":"The use of clozapine in a mentally retarded and aggressive population","volume":"55","author":"Cohen","year":"1994","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.ridd.2010.07.003_bib5","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.ridd.2008.10.010","article-title":"Practice guidelines for the use of new generation antipsychotic drugs (except clozapine) in adult individuals with intellectual disabilities","volume":"30","author":"deLeon","year":"2009","journal-title":"Research in Developmental Disabilities"},{"key":"10.1016\/j.ridd.2010.07.003_bib6","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/BF02178191","article-title":"The effect of clozapine on self-injurious behavior","volume":"25","author":"Hammock","year":"1995","journal-title":"Journal of Autism and Developmental Disorders"},{"key":"10.1016\/j.ridd.2010.07.003_bib7","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1023\/A:1005626100084","article-title":"Brief report: Effects of clozapine on self-injurious behavior of two risperidone nonresponders with mental retardation","volume":"31","author":"Hammock","year":"2001","journal-title":"Journal of Autism and Developmental Disorders"},{"key":"10.1016\/j.ridd.2010.07.003_bib8","series-title":"Child psychopathology","first-page":"486","article-title":"Mental retardation (intellectual disabilities)","author":"Hodapp","year":"2003"},{"key":"10.1016\/j.ridd.2010.07.003_bib9","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ridd.2008.03.003","article-title":"The overlap between psychiatric symptoms and challenging behaviour: A preliminary study","volume":"30","author":"Holden","year":"2009","journal-title":"Research in Developmental Disabilities"},{"key":"10.1016\/j.ridd.2010.07.003_bib10","first-page":"268","article-title":"Psychoactive drug use in public and community residential facilities for mentally retarded persons","volume":"21","author":"Intagliata","year":"1985","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1016\/j.ridd.2010.07.003_bib11","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1017\/S0790966700005024","article-title":"The use of clozapine in an individual with moderate intellectual disability, aggressive behavior and resistant psychosis","volume":"16","author":"Kamal","year":"1999","journal-title":"Journal of Psychological Medicine"},{"issue":"Suppl. 17","key":"10.1016\/j.ridd.2010.07.003_bib12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1192\/S0007125000296918","article-title":"Clinical efficacy of clozapine in treatment-refractory schizophrenia: An overview","volume":"160","author":"Kane","year":"1992","journal-title":"British Journal of Psychiatry"},{"key":"10.1016\/j.ridd.2010.07.003_bib13","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.ridd.2008.08.007","article-title":"Psychotropic medication use for challenging behaviors in persons with intellectual disabilities: An overview","volume":"30","author":"Matson","year":"2009","journal-title":"Research in Developmental Disabilities"},{"key":"10.1016\/j.ridd.2010.07.003_bib14","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.ridd.2009.06.003","article-title":"Intellectual disability and its relationship to autism spectrum disorders","volume":"30","author":"Matson","year":"2009","journal-title":"Research in Developmental Disabilities"},{"key":"10.1016\/j.ridd.2010.07.003_bib15","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0891-4222(98)00021-3","article-title":"Reliability of the Matson evaluation of drug side effects scale (MEDS)","volume":"19","author":"Matson","year":"1998","journal-title":"Research in Developmental Disabilities"},{"key":"10.1016\/j.ridd.2010.07.003_bib16","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0891-4222(00)00042-1","article-title":"Psychopharmacology and mental retardation: A 10 year review (1990\u20131999)","volume":"21","author":"Matson","year":"2000","journal-title":"Research in Developmental Disabilities"},{"key":"10.1016\/j.ridd.2010.07.003_bib17","series-title":"Psychotropic drug fast facts","author":"Maxmen","year":"2008"},{"key":"10.1016\/j.ridd.2010.07.003_bib18","first-page":"323","article-title":"Clozapine in three individuals with mild mental retardation and treatment refractory psychiatric disorders","volume":"32","author":"Pary","year":"1994","journal-title":"Mental Retardation"},{"key":"10.1016\/j.ridd.2010.07.003_bib19","first-page":"219","article-title":"The effects of clozapine on severely aggressive psychiatric inpatients in a state hospital","volume":"54","author":"Ratey","year":"1993","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.ridd.2010.07.003_bib20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0010-440X(94)90166-X","article-title":"The use of clozapine in borderline-intellectual-functioning and mentally retarded schizophrenic patients","volume":"35","author":"Sajatovic","year":"1994","journal-title":"Comprehensive Psychiatry"},{"key":"10.1016\/j.ridd.2010.07.003_bib21","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/mrdd.1410010208","article-title":"Clinical trials of D1 and D2 dopamine modulating drugs and self-injury in mental retardation and developmental disability","volume":"1","author":"Schroeder","year":"1995","journal-title":"Mental Retardation and Developmental Disabilities Research News"},{"key":"10.1016\/j.ridd.2010.07.003_bib22","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ridd.2008.03.004","article-title":"Linguistic lateralization in adolescents with Down Syndrome revealed by a dichotic monitoring test","volume":"30","author":"Shoji","year":"2009","journal-title":"Research in Developmental Disabilities"},{"key":"10.1016\/j.ridd.2010.07.003_bib23","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10882-008-9129-1","article-title":"An examination of psychotropic medication prescription practices for individuals with intellectual disabilities","volume":"21","author":"Singh","year":"2009","journal-title":"Journal of Developmental and Physical Disabilities"},{"key":"10.1016\/j.ridd.2010.07.003_bib24","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ridd.2004.07.001","article-title":"The use of risperidone among individuals with mental retardation: Clinically supported or not?","volume":"26","author":"Singh","year":"2005","journal-title":"Research in Developmental Disabilities"},{"key":"10.1016\/j.ridd.2010.07.003_bib25","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ridd.2008.04.003","article-title":"Patterns of intellectual, adaptive and behavioral functioning in individuals with mild mental retardation","volume":"30","author":"Soenen","year":"2009","journal-title":"Research in Developmental Disabilities"},{"key":"10.1016\/j.ridd.2010.07.003_bib26","series-title":"International Review of Research in Mental Retardation","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0074-7750(08)60147-0","article-title":"Methodology of psychopharmacological studies with the retarded","author":"Sprague","year":"1971"},{"key":"10.1016\/j.ridd.2010.07.003_bib27","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/j.1365-2788.2004.00626.x","article-title":"The use of clozapine in adults with intellectual disability","volume":"28","author":"Thalayasingam","year":"2004","journal-title":"Journal of Intellectual Disability Research"},{"key":"10.1016\/j.ridd.2010.07.003_bib28","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/080394899426828","article-title":"A follow-up of medical treatment of persons with psychiatric health problems and mental retardation","volume":"53","author":"Thuresson","year":"1999","journal-title":"Nordic Journal of Psychiatry"},{"key":"10.1016\/j.ridd.2010.07.003_bib29","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.ridd.2009.04.005","article-title":"Memory profiles with mild intellectual disabilities: Strengths and weaknesses","volume":"30","author":"Van der Molen","year":"2009","journal-title":"Research in Developmental Disabilities"},{"key":"10.1016\/j.ridd.2010.07.003_bib30","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.ridd.2008.12.005","article-title":"Focus on interaction: The use of an individualized support program for persons with profound intellectual and multiple disabilities","volume":"30","author":"VlasKamp","year":"2009","journal-title":"Research in Developmental Disabilities"},{"key":"10.1016\/j.ridd.2010.07.003_bib31","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1055\/s-0028-1094426","article-title":"The treatment of behavior disorders in idiocy and imbecility with clozapine","volume":"7","author":"Vyncke","year":"1974","journal-title":"Pharmakopsychiatry and Neuropsychopharmakology"},{"key":"10.1016\/j.ridd.2010.07.003_bib32","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.ridd.2009.01.007","article-title":"Support for the construct validity of the Supports Intensity Scale based on clinical ranking of need","volume":"30","author":"Weiss","year":"2009","journal-title":"Research in Developmental Disabilities"},{"key":"10.1016\/j.ridd.2010.07.003_bib33","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/BF02684960","article-title":"An evaluation of clozapine combined with behavioral intervention in the treatment of aggression and tantrums in a woman with mental retardation and schizophrenia","volume":"7","author":"Williams","year":"1995","journal-title":"Journal of Developmental and Physical Disabilities"},{"key":"10.1016\/j.ridd.2010.07.003_bib34","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.ridd.2009.06.002","article-title":"Determinants of prescription drug use by adolescents with intellectual disabilities in Taiwan","volume":"30","author":"Yen","year":"2009","journal-title":"Research in Developmental Disabilities"}],"container-title":["Research in Developmental Disabilities"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891422210001599?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891422210001599?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T09:04:39Z","timestamp":1559379879000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891422210001599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0891422210001599"],"URL":"https:\/\/doi.org\/10.1016\/j.ridd.2010.07.003","relation":{},"ISSN":["0891-4222"],"issn-type":[{"value":"0891-4222","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}